Lung-RADS Category

Lung cancer kills more people than any other cancer, and the reason is timing. Most of it is found after it has spread, when it is hard to treat. Found early, while it is still a small spot in the lung, it is often curable.

Lung-RADS (Lung CT Screening Reporting and Data System) is how a radiologist tells you where a screening scan puts you. It sorts any spots in your lungs into a short set of tiers, from nothing to act on now up to a spot that needs a close look soon. A low number means keep screening yearly. A high number means something on the scan needs attention.

What Each Category Means

The system runs from 1 up to 4X, and the number is not a diagnosis. It is a bet on the odds, based on the size, shape, and density of what shows up, plus whether it is new or growing compared with an earlier scan.

• Category 1: negative. No nodules, or only ones that look clearly harmless. Cancer turns up in only about 1 to 2 of every 1,000 such scans. You go back to yearly screening.
• Category 2: benign appearance. Small nodules, or ones with a shape and density that read as benign. This still counts as a negative screen, so you stay on yearly screening. Benign appearance means low odds, not zero.
• Category 3: probably benign. A nodule big enough or new enough that the plan is a repeat scan in about six months instead of waiting a full year.
• Category 4A: suspicious. A nodule in a size range where cancer is a real possibility. The usual next step is a shorter-interval CT or a PET scan.
• Category 4B: more suspicious, and larger. Often a PET scan or a biopsy.
• Category 4X: any nodule the radiologist bumps up because it has cancer-like features, such as spiky edges, pulling on the lung lining, or a ragged cavity. The highest-risk tier.
• Category S: an add-on letter for a significant or possibly significant finding that has nothing to do with lung nodules, most often coronary artery calcium or an enlarged lymph node. It rides alongside the number, so a report can read "2S."

How the Number Tracks Cancer Risk

The whole point of the tiers is that cancer risk climbs steeply as the number rises. In a national registry of more than a million U.S. screens, cancer was found in about 3 of every 100 category 4A scans, roughly 11 of every 100 category 4B, and about 20 of every 100 category 4X. Category 3 sits far lower, below the 4A rate.

The numbers run higher at a first screening scan than at later ones, because a baseline scan catches spots that have been sitting there for years. In the large U.S. trial, cancer was present in about a third of category 4B nodules at that first look. What all of this means for you is simple: the category is a decent read on how worried to be, and a 4 is a reason to keep going, not a verdict.

Why Finding It Early Is the Whole Point

Screening earns its keep by shifting cancers into an earlier, treatable stage. In the national registry, more than half of screen-detected cancers were stage I, the earliest and most curable stage. That is the opposite of the usual pattern, where lung cancer is found late.

This is why a suspicious category is worth acting on quickly even though most suspicious nodules are not cancer. The few that are get caught while they are small. A spot found at stage I is a very different situation from the same spot found two years later after it has spread.

The False Alarm Problem, and How This Fixes It

The main knock on lung screening used to be false alarms, and this system was built to fix that. Compared with the older trial rules, it cut the false-positive rate at a first scan from about 27 in 100 down to 13 in 100, and at follow-up scans from about 22 in 100 down to 5 in 100. In a rural program, treating only 4B and 4X as positive dropped the false-positive rate to under 2 in 100, on par with mammography. In a diverse urban clinic the rate roughly halved versus the old criteria, and applying the system raised the share of positives that were truly cancer about 2.5-fold.

There is a catch worth understanding. The system does catch slightly fewer cancers on any single scan than the old rules did, about 85 of every 100 versus 94. That sounds like the wrong trade until you remember two things. Screening repeats every year, so a growing cancer that looked benign this time declares itself by growing and gets caught next time. And a large cut in false alarms spares many people needless biopsies for spots that were never cancer. This is not a good-number, bad-number marker; it is a risk sorter tuned to be repeated over years, and it accepts a small miss rate on each scan to avoid a flood of false positives.

When the Category Can Mislead

• Two readers can disagree: radiologists land on different categories in roughly a fifth to a third of paired readings, and it changes what happens next in about 8 of every 100. The usual cause is that they pick a different nodule as the one that matters. Agreement improves with dedicated screening software.
• Old scars and infections: in regions where tuberculosis is common, healed scars drag specificity down and generate extra false positives. A recent infection or inflammation can throw a spot that looks worrying and then vanishes; up to a third of high-risk hazy nodules turn out to be temporary, which is why a short repeat scan often comes before anything invasive.
• Which version was used: the system has been revised over time, and updates have reclassified certain nodules, such as ones tucked against a fissure or along an airway. The same spot can land in a different category depending on which version your lab applies.
• A routine scan is not a screen: a standard chest CT or X-ray done for another reason is not read against this system at all. A clear ordinary scan is not the same as a negative screening result, and treating it that way is false reassurance.

Why One Scan Is Just the Start

This is a marker you read as a trajectory, not a snapshot. Several categories hinge on comparison with a prior scan: a stable nodule and a growing one of the same size can land in very different tiers. Growth over time is the single clearest signal that a spot is waking up rather than sitting inert.

If you are eligible, get a baseline scan now, then follow the interval your category sets: yearly for a 1 or 2, six months for a 3, sooner for a 4. Then keep going every year. The weak link is follow-through, not the scan itself. Only about 57 of every 100 people come back on schedule, and a missed next scan throws away most of the method's value.

What to Do With a 3 or a 4

A category 3 is a wait-and-look plan: a repeat CT in about six months to see whether the nodule grows. Most do not. A 4A usually means a shorter-interval CT or a PET scan, which highlights metabolically active tissue. A 4B or 4X points toward a PET scan and a conversation with a pulmonologist or thoracic surgeon about whether to biopsy or keep imaging.

Some combinations should push you to move faster: a nodule that is growing, spiky or ragged margins, or a smoker who also has emphysema, which raises the cancer rate within a given category, often close to double. Two practical steps help. Bring any old chest images so the reader can judge growth, and given how often readers disagree, a second read is reasonable for a borderline call. The category tells you the odds; a companion PET scan or biopsy tells you what the spot actually is.